CDKN2A and head and neck squamous cell carcinoma: The most common epigenetic modification in HNSCC is DNA hypermethylation in the promoter region of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene encoding for tumor suppressor p16INK4a that results in enhanced cellular proliferation [146].